Stay updated on Efgartigimod in ITP Clinical Trial
Sign up to get notified when there's something new on the Efgartigimod in ITP Clinical Trial page.

Latest updates to the Efgartigimod in ITP Clinical Trial page
- Check7 days agoChange DetectedThe version history now includes a new revision tag: Revision: v3.3.3. The HHS Vulnerability Disclosure and Revision: v3.3.2 entries were removed from the page footer, and to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check35 days agoChange DetectedFooter revision updated from v3.2.0 to v3.3.2. No changes to study data or navigation are evident.SummaryDifference0.1%

- Check42 days agoChange DetectedRemoved the banner notice about government funding and operating status from the page header. The change affects only a site-wide status message, not trial data or navigation.SummaryDifference0.5%

- Check57 days agoChange DetectedThe new screenshot shows small UI tweaks to the Record History page, including spacing and label adjustments, with the core list of study record versions remaining unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check85 days agoChange DetectedAdded a government funding lapse notice and a v3.2.0 version tag, replacing the prior v3.1.0.SummaryDifference11%

- Check93 days agoChange DetectedUpdated the site version from v3.0.2 to v3.1.0, indicating a new release; no other page content changes were detected.SummaryDifference0.3%

Stay in the know with updates to Efgartigimod in ITP Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efgartigimod in ITP Clinical Trial page.